CrcB functions as a fluoride efflux pump under the regulation of fluoride riboswitches . Key features include:
Fluoride Sensing: Fluoride riboswitches (crcB RNA motifs) activate CrcB expression upon elevated fluoride concentrations .
Transport Activity: CrcB reduces intracellular fluoride levels via proton-coupled antiport, mitigating toxicity .
Symbiotic Adaptation: In Burkholderia species, fluoride resistance supports survival in fluoride-rich environments, including plant rhizospheres .
Pathogen Competition: CrcB homologs in pathogenic Burkholderia enhance fitness during host interactions .
Fluoride Transport Studies: Used to characterize kinetics and inhibition of fluoride/proton antiport in vitro .
Riboswitch Interactions: Investigates transcriptional regulation of crcB genes under fluoride stress .
Structural Biology: Aids in crystallography and mutagenesis studies to map functional domains .
Research gaps include resolving the atomic structure of CrcB and engineering hyperactive variants for bioremediation. Additionally, interspecies comparisons of CrcB homologs could elucidate evolutionary adaptations to fluoride-rich niches .
Crucial for reducing intracellular fluoride concentration, thereby mitigating its toxicity.
KEGG: bph:Bphy_1762
STRING: 391038.Bphy_1762
The CrcB homolog in Burkholderia phymatum belongs to a family of membrane proteins widely distributed across bacterial species, with significant sequence conservation. While direct characterization of B. phymatum CrcB remains limited, comparative genomic analyses indicate structural similarity to other Burkholderia species homologs, particularly those of B. pseudomallei and B. thailandensis, which typically share high sequence identity (>90%) among closely related Burkholderia species . The protein likely contains transmembrane domains characteristic of the CrcB family, which are involved in ion transport across cell membranes. Similar to other bacterial homologs, the B. phymatum CrcB homolog likely functions in fluoride ion export and resistance mechanisms, protecting cellular processes from fluoride toxicity. Phylogenetic analysis would place this protein within the broader context of bacterial ion channels and transporters, with potential unique adaptations specific to B. phymatum's environmental niche.
E. coli expression systems represent the preferred platform for recombinant production of B. phymatum CrcB homolog protein due to their established protocols, high yield potential, and compatibility with bacterial membrane proteins . When selecting an expression system, researchers should consider using BL21(DE3) or Rosetta strains harboring pET vectors containing a 6xHis-tag at either the N- or C-terminus to facilitate purification. Expression conditions typically require optimization of IPTG concentration (0.1-1.0 mM), induction temperature (16-37°C), and duration (4-24 hours) to maximize protein yield while minimizing inclusion body formation. For membrane proteins like CrcB homologs, lower induction temperatures (16-25°C) often promote proper folding and membrane integration. Alternative expression systems such as Burkholderia species themselves might provide more native-like post-translational modifications but typically yield lower protein quantities. The choice between prokaryotic and eukaryotic expression systems should be guided by the specific research objectives, with the understanding that prokaryotic systems may lack certain post-translational modifications potentially present in native B. phymatum.
Based on characterized CrcB homologs, the B. phymatum CrcB protein likely adopts a transmembrane structure with multiple membrane-spanning regions. Typical CrcB homologs contain approximately 3-4 transmembrane domains with conserved charged residues positioned strategically for ion channel formation and selectivity . The protein would be expected to have a molecular weight between 12-15 kDa for each monomer, though functional complexes likely form higher-order oligomeric structures, potentially dimers or tetramers. The protein would share structural similarities with the human CrcB homolog 2 protein, which contains 126 amino acids and forms a transmembrane channel . Conserved motifs likely include regions involved in ion selectivity, particularly residues that coordinate fluoride ions, which are typically negatively charged amino acids positioned within the channel pore. The three-dimensional structure would be expected to form a channel-like architecture similar to other ion transport proteins, with a central pore lined with hydrophilic residues facilitating ion movement across the hydrophobic membrane barrier.
Purification of recombinant B. phymatum CrcB homolog protein while preserving its native conformation requires a carefully optimized protocol that accounts for its transmembrane nature. The recommended approach begins with cell lysis using mild detergents such as n-dodecyl-β-D-maltoside (DDM) at 1-2% concentration or CHAPS at 0.5-1.0% to solubilize membrane fractions without denaturing the protein structure . Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin represents the primary purification step, with binding buffer containing 20-50 mM imidazole to reduce non-specific binding while maintaining specific interaction of the His-tagged protein. Elution should employ a gradient of 100-500 mM imidazole in buffer containing 0.05-0.1% detergent to maintain protein solubility. Size exclusion chromatography serves as a secondary purification step, using columns such as Superdex 200 with buffers containing reduced detergent concentrations (0.03-0.05%) to minimize interference with downstream applications. Throughout purification, maintaining physiologically relevant pH (7.0-7.5) and including glycerol (5-10%) enhances protein stability. Validation of protein structure post-purification should include circular dichroism spectroscopy to confirm secondary structure elements and size exclusion chromatography-multi-angle light scattering (SEC-MALS) to determine oligomeric state, which is crucial for understanding the functional unit of the CrcB homolog.
Designing functional assays for characterizing ion transport properties of recombinant B. phymatum CrcB homolog requires methodology that maintains protein functionality while providing quantitative measurements of ion flux. Researchers should consider implementing liposome-based flux assays where purified CrcB homolog is reconstituted into artificial liposomes loaded with ion-sensitive fluorescent dyes (such as SBFI for sodium or PBFI for potassium) to monitor real-time ion transport across membranes upon creation of an ion gradient . Electrophysiological approaches using planar lipid bilayers represent another powerful technique, allowing precise measurement of channel conductance, ion selectivity, and gating properties by applying voltage clamps and measuring resulting currents across membranes containing the reconstituted protein. Isothermal titration calorimetry can provide thermodynamic parameters of ion binding, while ion competition assays using radioactive ion tracers (such as 36Cl- or 18F-) can determine selectivity profiles among different anions. Cell-based assays utilizing fluoride-sensitive bacterial growth in cells expressing the recombinant protein can serve as functional validation systems, particularly when combined with site-directed mutagenesis of predicted pore-forming residues. When designing these assays, researchers should systematically vary ion concentrations (typically 1-100 mM), membrane potential (-100 to +100 mV), and pH conditions (5.5-8.0) to fully characterize the transport mechanism and physiological relevance of the B. phymatum CrcB homolog.
Investigation of protein-protein interactions involving B. phymatum CrcB homolog requires complementary approaches that capture both stable and transient interactions within bacterial systems. Co-immunoprecipitation combined with mass spectrometry represents a foundational technique, ideally using antibodies against the native protein or epitope tags incorporated into the recombinant construct . Bacterial two-hybrid assays offer an alternative approach, where potential interacting partners can be systematically screened by fusing the CrcB homolog to one domain of a split transcription factor and candidate partners to the complementary domain. Chemical cross-linking coupled with mass spectrometry provides spatial information about interacting regions, while proximity-dependent biotin labeling (BioID or APEX) can capture even transient interactions in the native membrane environment. Fluorescence resonance energy transfer (FRET) using fluorescently tagged proteins expressed in B. phymatum or model bacterial systems allows visualization of interactions in living cells, providing spatial and temporal information. Mutational analysis targeting potential interaction domains should be conducted systematically, with each mutation assessed for its impact on both protein function and interaction capability. For data analysis, researchers should implement stringent statistical filters to distinguish true interactions from background, typically requiring multiple peptide identifications, reproducibility across biological replicates, and validation through orthogonal methods such as co-localization studies or pull-down assays with purified components.
When designing experiments to investigate the role of B. phymatum CrcB homolog in fluoride resistance mechanisms, researchers should implement a multi-faceted approach combining genetic, biochemical, and physiological methods. The experimental design should begin with generation of CrcB knockout strains using CRISPR-Cas9 or homologous recombination techniques, alongside complementation strains expressing either wild-type or mutated versions of the CrcB homolog . Growth curve analyses should be conducted under varying fluoride concentrations (typically 0.5-20 mM NaF) while monitoring multiple parameters including lag phase duration, doubling time, and maximum optical density. Intracellular fluoride concentrations should be quantified using fluoride-selective electrodes or fluorescent indicators, comparing wild-type, knockout, and complemented strains to establish direct correlation between CrcB function and fluoride export. Membrane potential measurements using voltage-sensitive dyes can determine whether fluoride transport is coupled to electrochemical gradients. Site-directed mutagenesis targeting conserved residues predicted to be involved in fluoride coordination should be conducted systematically, with each mutant assessed for fluoride resistance to identify critical functional domains. Time-resolved transcriptomic analysis under fluoride stress conditions can reveal whether B. phymatum employs regulatory mechanisms similar to other bacteria, where fluoride exposure triggers expression of resistance genes. For comprehensive analysis, fluoride resistance experiments should be conducted under varying pH conditions (5.5-8.0) and in the presence of competing anions (Cl-, Br-, HCO3-) to determine the selectivity and environmental modulation of the CrcB homolog's function in fluoride detoxification mechanisms.
Successful crystallization and structural determination of B. phymatum CrcB homolog requires specialized approaches optimized for membrane proteins. Researchers should initially focus on producing large quantities (5-10 mg) of highly pure (>95%), homogeneous protein using detergent screening to identify optimal solubilization conditions that maintain native conformation . Vapor diffusion techniques (hanging or sitting drop) represent the primary crystallization approach, with specialized membrane protein screens such as MemGold or MemSys as starting points. Lipidic cubic phase crystallization offers an alternative approach that can better maintain the protein in a membrane-like environment. Optimization strategies should include systematic variation of protein concentration (5-15 mg/mL), precipitant type and concentration, pH (5.5-8.5), temperature (4-20°C), and addition of specific additives including fluoride ions that may stabilize the channel conformation . For challenging membrane proteins like CrcB homologs, protein engineering approaches such as truncation of flexible regions, insertion of crystallization chaperones (e.g., T4 lysozyme or BRIL), or generation of Fab fragments against the protein can enhance crystallizability. X-ray diffraction data collection typically requires synchrotron radiation sources due to small crystal size and potential radiation sensitivity. Alternatively, single-particle cryo-electron microscopy represents a powerful approach for structural determination without crystallization, particularly suitable for membrane proteins that form higher-order oligomers. Phase determination often requires heavy atom derivatives or selenomethionine incorporation, with molecular replacement using distantly related structures as another possibility. Validation of the final structure should include assessment of stereochemistry, Ramachandran statistics, and functional studies of residues identified as critical in the structural model.
Rigorous controls and validation methods are essential when investigating interactions between B. phymatum CrcB homolog and other cellular components to distinguish specific interactions from experimental artifacts. Researchers should implement negative controls including non-specific antibodies or irrelevant tagged proteins in immunoprecipitation experiments, empty vector controls in bacterial two-hybrid assays, and scrambled peptides in binding studies . Positive controls should include known interacting protein pairs tested in parallel with the experimental samples. Validation of detected interactions requires confirmation through at least two independent methodological approaches (e.g., co-immunoprecipitation followed by FRET or split-GFP complementation). Dose-dependence studies where one component is systematically varied in concentration can establish specificity and binding parameters. Competition assays using unlabeled proteins to displace labeled interaction partners provide further validation of binding specificity. When analyzing interaction data, statistical thresholds for significance should be clearly defined and consistently applied, typically requiring p-values <0.01 and multiple peptide identifications in mass spectrometry-based approaches. Biological relevance should be assessed through correlation with phenotypic outcomes, such as changes in fluoride sensitivity or altered membrane transport upon disruption of the identified interaction. Domain mapping through truncation or point mutations should identify specific interaction regions within the CrcB homolog, with reciprocal mutations in partner proteins validating the interaction interface. Finally, researchers should consider the physiological context of detected interactions, including subcellular localization, expression timing, and environmental conditions that might regulate the interaction in vivo.
Expression of recombinant B. phymatum CrcB homolog presents several challenges common to membrane proteins, requiring systematic troubleshooting approaches. Protein toxicity during expression represents a frequent obstacle, manifesting as slow growth or plasmid instability in expression hosts . This can be addressed by using tightly regulated promoters (such as pBAD or lac-based systems with glucose repression), lowering growth temperature to 16-20°C, and employing specialized E. coli strains like C41(DE3) or C43(DE3) designed for toxic membrane protein expression. Inclusion body formation often occurs due to improper membrane integration, requiring optimization of induction conditions (typically reducing IPTG concentration to 0.1-0.2 mM and extending expression time to 16-24 hours at lower temperatures). Addition of specific membrane-mimetic environments during lysis and purification represents another critical factor, with systematic screening of detergents (DDM, LDAO, CHAPS) at various concentrations (0.5-2%) to identify optimal solubilization conditions. Proteolytic degradation can be minimized by including protease inhibitor cocktails and working rapidly at 4°C throughout purification. Low expression yields may be improved by codon optimization for the expression host or fusion to solubility-enhancing tags such as MBP or SUMO, though these require careful assessment of tag removal efficiency. For proteins proving particularly recalcitrant to expression, cell-free systems represent an alternative approach, allowing direct incorporation into liposomes or nanodiscs. Validation of proper folding should include functional assays specific to ion transport activity, as well as biophysical characterization using circular dichroism or fluorescence spectroscopy to confirm secondary structure integrity.
Effective analysis and interpretation of comparative genomic data for B. phymatum CrcB homolog requires a structured bioinformatic workflow that integrates sequence, structural, and functional information across bacterial species. Researchers should begin with comprehensive homology searches using iterative methods like PSI-BLAST or HMMer against diverse bacterial genomic databases, applying an E-value threshold of 10^-10 to identify true homologs . Multiple sequence alignment using tools such as MUSCLE or MAFFT should be carefully curated, focusing on conserved transmembrane regions and potential ion coordination sites. Phylogenetic reconstruction using maximum likelihood or Bayesian methods provides evolutionary context, ideally incorporating models specific for membrane proteins that account for different evolutionary rates in transmembrane versus loop regions. Genomic context analysis examining neighboring genes can reveal functionally related operons or gene clusters that might participate in coordinated biological processes. Structural prediction using AlphaFold2 or RoseTTAFold can generate comparative models for species lacking experimental structures, with model quality assessment focusing on transmembrane region accuracy. Functional prediction should integrate information from characterized homologs, considering both highly conserved residues (likely involved in core functions like ion selectivity) and variable regions (potentially involved in species-specific adaptations or regulatory interactions). When analyzing conservation patterns, researchers should distinguish between absolute conservation (identical residues) and physico-chemical conservation (substitutions maintaining similar properties), as the latter may still preserve functional characteristics. Statistical analysis should include calculation of dN/dS ratios to identify regions under selective pressure, and information-theoretic approaches to quantify conservation at specific positions. This comprehensive analysis framework enables researchers to generate testable hypotheses about B. phymatum CrcB homolog function based on evolutionary patterns observed across bacterial species.
When faced with contradictory experimental results in characterizing B. phymatum CrcB homolog function, researchers should implement a systematic approach to identify and resolve discrepancies. The initial step involves detailed analysis of methodological differences between conflicting studies, examining variables such as protein expression conditions, purification methods, lipid/detergent environments, and assay conditions that might influence protein functionality . Researchers should directly replicate key experiments using standardized protocols across multiple laboratories to determine reproducibility, ideally implementing blinded analysis to minimize bias. Testing function across a range of conditions (pH 5.5-8.0, temperature 20-37°C, varying ion concentrations 1-100 mM) can reveal condition-dependent behaviors that explain seemingly contradictory results obtained under different experimental settings. Alternative hypotheses should be systematically evaluated, considering possibilities such as dual functionality, allosteric regulation, or conformational changes that might reconcile opposing observations. Methodological triangulation using orthogonal techniques to measure the same functional parameter provides stronger evidence than relying on a single approach. For example, ion transport could be assessed using electrophysiology, fluorescence-based flux assays, and growth-based functional complementation to provide a more comprehensive functional profile. When contradictions persist, genetic background effects should be considered, as differences in expression systems or the presence of auxiliary proteins may modify CrcB homolog function. Mathematical modeling of experimental data can sometimes reconcile seemingly contradictory results by identifying complex relationships between experimental variables and functional outcomes. Finally, researchers should consider whether post-translational modifications or protein damage during preparation might contribute to functional heterogeneity, implementing methods such as mass spectrometry to characterize the exact protein species being tested in each experimental setup.
Emerging technologies across multiple disciplines offer transformative potential for advancing our understanding of B. phymatum CrcB homolog structure and function. Cryo-electron tomography represents a powerful approach for visualizing membrane proteins in their native cellular environment, potentially revealing the organization of CrcB homologs within bacterial membranes without artifacts introduced by detergent solubilization . Advanced microfluidics combined with patch-clamp electrophysiology enables high-throughput functional characterization of ion channels under precisely controlled conditions, allowing systematic exploration of the relationship between sequence variations and functional properties. Time-resolved structural methods including time-resolved crystallography and temperature-jump FRET can capture conformational dynamics during ion transport, providing insights into the mechanical basis of selectivity and gating. Artificial intelligence approaches, particularly AlphaFold2 and RoseTTAFold, can generate increasingly accurate structural models of membrane proteins and their complexes, accelerating hypothesis generation when experimental structures remain challenging. Single-molecule techniques including fluorescence correlation spectroscopy and single-molecule FRET offer unique insights into conformational heterogeneity and dynamics that might be obscured in ensemble measurements. CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) technologies enable precise modulation of gene expression in native bacterial contexts, allowing fine-tuned assessment of CrcB homolog function under physiologically relevant conditions. Integration of these technologies with systems biology approaches, particularly multi-omics strategies combining transcriptomics, proteomics, and metabolomics, will provide comprehensive understanding of how CrcB homologs participate in bacterial response networks under various environmental stresses including fluoride exposure.
Comparative analysis between B. phymatum CrcB homolog and homologs in pathogenic Burkholderia species offers strategic insights for therapeutic development targeting these clinically significant pathogens. Sequence alignment and structural modeling of CrcB homologs across B. pseudomallei, B. mallei, B. cenocepacia, and other pathogenic species can identify both conserved regions critical for function and unique features that might enable selective targeting . Researchers should systematically compare ion selectivity, transport kinetics, and regulatory mechanisms across species using equivalent methodological approaches to identify functional divergence that might correlate with pathogenicity or environmental adaptation. High-throughput screening campaigns targeting identified functional domains of pathogenic species' CrcB homologs could identify inhibitors that disrupt ion homeostasis as potential antimicrobial agents. Structure-based drug design approaches would benefit from detailed comparative analysis of CrcB binding pockets, particularly identifying unique structural features in pathogenic species that could be exploited for selective targeting. Genetic manipulation studies comparing the phenotypic consequences of CrcB disruption across pathogenic and non-pathogenic Burkholderia species can establish the therapeutic potential of targeting this protein family, particularly evaluating effects on virulence, antibiotic susceptibility, and survival under host-relevant conditions. Pharmacological validation would require testing candidate inhibitors against both isolated proteins and bacterial growth models, ideally including infection models to evaluate in vivo efficacy. The comparative approach should extend to examining CrcB homolog interactions with host factors during infection, potentially identifying additional therapeutic targets within these interaction networks. This systematic comparative strategy between B. phymatum and pathogenic Burkholderia species CrcB homologs could ultimately yield novel therapeutic approaches targeting a protein family essential for bacterial survival, addressing the urgent need for new antibiotics against these often multidrug-resistant pathogens.